Shearman & Sterling advised CVS Health Corporation (CVS Health) on its $4 billion bond offering and related cash tender offers for five series of its outstanding notes. Barclays Capital Inc., BofA Securities, Inc. and Goldman Sachs & Co. LLC acted as joint book-running managers on the bond offering. Barclays Capital Inc., Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC acted as dealer managers for the tender offers.

CVS Health’s $4 billion bond offering consisted of $1.5 billion of its 1.3% senior notes due 2027, $1.25 billion of its 1.75% senior notes due 2030 and $1.25 billion of its 2.7% senior notes due 2040. Proceeds from the notes offering were used to repurchase notes tendered in the related cash tender offers for five series of its outstanding notes.

The Shearman & Sterling team below also included associate Alex Liebmann.

The Team